Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 7 Smoking 1 Sarcoma 1 Pulmonary Fibrosis 1 Pneumonia 1 Lung Diseases, Interstitial 1 Hemoptysis 1 Carcinoma, Squamous Cell 1

Interventions

Doxorubicin 15 pembrolizumab 12 Cyclophosphamide 9 Surgical Procedures, Operative 8 Gemcitabine 8 Blood Specimen Collection 8 Ifosfamide 7 Surveys and Questionnaires 6 Nivolumab 6 Trabectedin 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Drug Therapy 5 fludarabine 4 Temozolomide 4 Specimen Handling 4 Radiation Dose Hypofractionation 4 Biopsy 4 selinexor 3 pazopanib 3 liposomal doxorubicin 3 cabozantinib 3 atezolizumab 3 anlotinib 3 Radiation 3 Observation 3 Docetaxel 3 Dacarbazine 3 trastuzumab deruxtecan 2 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma × Bronchoscopy × Clear all

NCT06815666 2026-03-04

BAL Fluid Biomarkers in Sarcoma

University Health Network, Toronto

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡